SCHEMBL11299470

SCHEMBL11299470

NC(=O)c1ccc(N(c2cccc(Cl)c2)C2CCNC2=O)cc1O

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 2/20 0.33
▸ PSEN1 P49768 1/20 0.32
▸ PSEN2 P49810 1/20 0.32
▸ APH1B Q8WW43 1/20 0.32
▸ NCSTN Q92542 1/20 0.32
▸ APH1A Q96BI3 1/20 0.32
▸ PSENEN Q9NZ42 1/20 0.32
▸ ABL1 P00519 1/20 0.32
▸ RIN1 Q13671 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ HTR3E A5X5Y0 1/20 0.32
▸ HTR3B O95264 1/20 0.32
▸ HTR3A P46098 1/20 0.32
▸ HTR3D Q70Z44 1/20 0.32
▸ HTR3C Q8WXA8 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ MKNK1 Q9BUB5 1/20 0.32
▸ MKNK2 Q9HBH9 1/20 0.32
▸ GHSR Q92847 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11301767 0.80 RPS6KB1 (0.42) MKNK2ALDH1A1MAP4K4PIM1
SCHEMBL11304382 0.78 HDAC8 (0.38) ABL1RIN1TDP1ALDH1A1
SCHEMBL11298752 0.77 HDAC8 (0.42) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL11296532 0.77 SLC6A3 (0.40) GAAGHSRALDH1A1TACR1L3MBTL1
SCHEMBL11303328 0.67 HDAC8 (0.37) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL12494089 0.66 PSEN1 (0.46) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL11306322 0.65 HDAC6 (0.37) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL11301754 0.65 PSEN1 (0.42) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL11302647 0.65 HDAC6 (0.43) —
SCHEMBL11301756 0.64 PARP1 (0.39) PARP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback